These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines. Pérez-Cuadrado-Robles E, Uribarri-González L, Borbath I, Vila JJ, López-López S, Deprez PH. Dig Liver Dis; 2019 Jun; 51(6):882-886. PubMed ID: 30591368 [Abstract] [Full Text] [Related]
9. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. Nguyen AH, Toste PA, Farrell JJ, Clerkin BM, Williams J, Muthusamy VR, Watson RR, Tomlinson JS, Hines OJ, Reber HA, Donahue TR. J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706 [Abstract] [Full Text] [Related]
16. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up. Schellhaas B, Vitali F, Wildner D, Görtz RS, Pfeifer L, Konturek PC, Neurath MF, Strobel D. Med Sci Monit; 2017 Mar 28; 23():1483-1492. PubMed ID: 28348359 [Abstract] [Full Text] [Related]
17. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Gastroenterology; 2017 Nov 28; 153(5):1284-1294.e1. PubMed ID: 28739282 [Abstract] [Full Text] [Related]
18. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. Uehara H, Ishikawa O, Katayama K, Kawada N, Ikezawa K, Fukutake N, Takakura R, Takano Y, Tanaka S, Takenaka A. J Gastroenterol; 2011 May 28; 46(5):657-63. PubMed ID: 21085997 [Abstract] [Full Text] [Related]